Verisian

🗓 Founded 2023👥 8 employees💰 Last funded Aug 2023
At Verisian, we envision a world where groundbreaking treatments are judged using all available evidence and the best tools, where the science is transparent to companies, regulators, and patients alike, and where patients have access to the latest cutting-edge treatments as soon as possible. We’re building innovation for clinical research and public health authorities. While CDISC standards like SDTM and ADaM have brought standardization for clinical trial data, lengthy analysis and submission cycles remain just as increasing trial complexity presents substantial challenges in decision-making and the potential for critical errors. The products we build empower researchers and regulators to analyze and monitor studies transparently in real-time, leading to improved and safer therapies for devastating diseases. Recognizing we cannot do this alone, were building a community for those who share our commitment and purpose. As we take this journey, were also expanding our team. If youve done exceptional work, join us in tackling the worlds most critical healthcare problem and lets shape the future together.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Verisian?
Verisian has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Verisian last raise funding?
The most recent investment in Verisian recorded on gritt.io was in August 2023.
When was Verisian founded?
Verisian was founded in 2023.
What industry is Verisian in?
Verisian operates in Software Development. Find similar Software Development investors on gritt.io.